ClinicalTrials.govpublic full text
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
mesothelioma, immunotherapy, checkpoint inhibitor, anti ctla-4, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 867574
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.